A prognostic model integrating clinical information and gene expression signatures in phase III neoadjuvant trial CALGB 40601(Alliance).

Tanioka, Maki ,  Parker, Joel S ,  Henry, Lynn N ,  Tolaney, Sara ... -  JSMO -  Ann Oncol -  2018  

Abstract -  Secondary-not-in-original Endpoint -  Primary Analysis -  Sequencing -  CALGB-40601